To Build or Not To Build? How Many Pharma-Biotech Capital Projects Actually Make Construction?
To Build or Not To Build? How Many Pharma-Biotech Capital Projects Actually Make Construction?
Attachment: Pharma-Biotech Industry 2006 vs. 2007 Gap Measurement Chart
The latest Gap Measurement figures from August 2007 revealed that the Pharmaceutical-Biotech Industry has 463 projects carrying a total investment value (TIV) of $15.8 billion ...
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
